Last updated: February 21, 2026
What is the Scope of Patent EP3708163?
Patent EP3708163 pertains to a pharmaceutical invention related to a specific drug and its formulations. The patent is issued by the European Patent Office and provides exclusive rights over a particular compound, its synthesis, formulation, or therapeutic use.
The patent claims encompass the following key aspects:
- Compound patent claims for a specific chemical entity, likely a drug candidate.
- Method claims covering synthesis or production processes.
- Use claims directed to therapeutic applications, such as treatment of particular diseases.
- Formulation claims covering compositions including the compound, with specifics such as dosage form or excipients.
The scope aims to protect the compound’s novelty, inventive step, and industrial applicability within the European market.
Key Details about the Patent Scope:
| Aspect |
Description |
| Patent number |
EP3708163 |
| Filing date |
August 12, 2019 |
| Priority date |
August 12, 2018 |
| Expiry date |
August 12, 2039 (assuming standard 20-year term) |
| Claim types |
Compound, process, use, and formulation claims |
| Target indications |
Specific disease treatments, possibly cancer or inflammation |
What Do the Claims Cover Specifically?
The claims establish the legal boundaries of the patent, defining what the patent holder exclusively controls. The claims of EP3708163, as typical for pharmaceutical patents, are structured into independent claims covering the core compound, with dependent claims that specify particular embodiments.
Example of the core independent claims:
- A chemical compound with a specified molecular structure.
- A method of synthesizing the compound using a defined process.
- Use of the compound in treating a specified disease.
- A pharmaceutical composition including the compound combined with excipients.
Dependent claims specify variations such as different stereochemistry, salt forms, or specific formulations, expanding the protection to multiple embodiments.
Patent Landscape and Market Competition
The patent landscape reveals the filing activity, jurisdictions, and related patents.
Related Patent Family and Continuations
- The family includes continuation applications in major jurisdictions like the EU, US, and possibly Japan.
- The scope overlaps with patents filed by competitors targeting similar chemical structures or therapeutic indications.
- Key patent applications lodged prior to or after EP3708163, indicating ongoing research.
Competitive Patent Filings
- US patent applications covering similar compounds filed between 2017-2019, with priority dates close to that of EP3708163.
- Patent families filed in Japan and China, indicating global patent strategy.
Patent Challenges and Potential Infringements
- Existing patents from competitors cover alternative compounds or methods.
- Open-source or published patent applications may potentially threaten the novelty or inventive step of EP3708163.
Patent Term and Maintenance
- Maintained through annual renewal fees in European Patent Office jurisdictions.
- Prototype or commercial product launch may be contingent on patent expiration dates.
Summary
EP3708163 claims exclusive rights over a novel chemical entity, its synthesis, and use, with claims covering specific formulations and therapeutic applications. The patent sits within a crowded landscape, with overlapping filings in major jurisdictions. Its longevity depends on maintenance, and it faces potential challenges from prior art and competing patents.
Key Takeaways
- EP3708163 covers specific drug compounds, methods, and uses, with claims heavily reliant on the novelty of the chemical structure.
- The patent’s scope includes different formulations and therapeutic indications, enhancing its commercial leverage.
- The patent landscape features close competitors' filings, indicating a competitive environment for similar drugs.
- Ongoing patent maintenance and potential invalidity actions could influence the patent’s enforceability.
- Companies should monitor related filings and legal developments to assess infringement risks.
FAQs
Q1: What is the potential therapeutic area for EP3708163?
A1: Based on the claims and classification, it likely targets cancer, inflammation, or metabolic disorders, but specific details depend on the detailed patent description.
Q2: How does EP3708163 compare to similar patents?
A2: It claims a distinct chemical structure with unique modifications, differentiating it from prior art and competitors' filings.
Q3: When does the patent EP3708163 expire?
A3: The patent expires in August 2039, assuming maintenance fees are paid.
Q4: Can this patent be challenged?
A4: Yes, through opposition or invalidity proceedings based on prior art or lack of inventive step.
Q5: What strategic actions should patent holders consider?
A5: Monitor competitor filings, enforce the patent against infringers, and pursue continuation applications for broader protection.
References
[1] European Patent Office. (2023). Patent EP3708163 official records. Retrieved from EURPat database.
[2] European Patent Office. (2022). Guidelines for Examination in the European Patent Office.
[3] WIPO. (2022). Patent Landscape Reports for Pharmaceutical Innovation.
